cysteine has been researched along with cyclosporine in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (20.00) | 18.2507 |
| 2000's | 9 (45.00) | 29.6817 |
| 2010's | 7 (35.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bravo, C; Chávez, E; Corona, N; Pichardo, J; Reyes-Vivas, H; Zazueta, C | 1 |
| Cambria, RJ; Gordon, RE; Heller, AN; Heller, DS; Schwimmer, A | 1 |
| Arakawa, M; Hasegawa, H; Nakano, M; Nishi, S; Saito, T; Ueno, M | 1 |
| Clarke, DM; Loo, TW | 2 |
| Florio, G; Marone, G; Patella, V; Petraroli, A; Triggiani, M | 1 |
| Chae, HZ; Hwang, YS; Kim, HJ; Kim, K; Kim, YJ; Kwon, KS; Lee, SP | 1 |
| Bartlett, MC; Clarke, DM; Loo, TW | 1 |
| Clavaud, C; Dugave, C; Heckenroth, M; Lelait, MA; Ménez, A; Stricane, C | 1 |
| Curti, C; Pardo-Andreu, GL; Pestana, CR; Rodrigues, FP; Santos, AC; Silva, CH; Uyemura, SA | 1 |
| Mimori, T; Yukawa, N | 1 |
| Arunkumar, J; Kalayarasan, S; Magendiramani, V; Nagendraprabhu, P; Sudhandiran, G; Umesalma, S | 1 |
| Huang, X; Ping, Q; Shen, J; Wang, Y; Xiao, Y | 1 |
| Ozer, JS | 1 |
| Erikson, JM; Lindsey, ML; Zhang, J | 1 |
| Deng, Y; Jin, X; Li, L; Ping, Q; Shen, J; Su, Z | 1 |
| Clavaud, C; Dugave, C; Le Gal, J; Thai, R | 1 |
| Ambrosio, AL; Barbosa, JA; Benedetti, CE; Brasil de Souza, Tde A; Campos, BM; Domingues, MN; Murakami, MT; Paes Leme, AF; Perez, CA; Sforça, ML; Whittaker, SB; Zeri, AC | 1 |
| Capodagli, GC; Federle, MJ; Khataokar, A; Neiditch, MB; Tylor, KM; Wilkening, RV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
4 review(s) available for cysteine and cyclosporine
| Article | Year |
|---|---|
[Drug-induced renal disorders in patients with rheumatoid arthritis].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Cysteine; Humans; Kidney Diseases; Methotrexate; ortho-Aminobenzoates | 1996 |
[Effect of disease modifying anti-rheumatic drugs on radiographic progression in rheumatoid arthritis].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Cysteine; Disease Progression; Drug Therapy, Combination; Gold Sodium Thiomalate; Humans; Isoxazoles; Leflunomide; Methotrexate; Penicillamine; Radiography; Randomized Controlled Trials as Topic; Sulfasalazine; Tacrolimus | 2009 |
A guidance for renal biomarker lead optimization and use in translational pharmacodynamics.
Topics: Albumins; Animals; Autoimmune Diseases; Bile Acids and Salts; Biomarkers, Pharmacological; Cathepsin B; Cyclosporine; Cystatin C; Cysteine; Diabetes Mellitus, Type 2; Drug Approval; Drug Evaluation, Preclinical; Humans; Immunosuppressive Agents; Kidney; Leukotrienes; Models, Animal; Translational Research, Biomedical | 2010 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
16 other study(ies) available for cysteine and cyclosporine
| Article | Year |
|---|---|
Triphenyltin as inductor of mitochondrial membrane permeability transition.
Topics: Animals; Calcium; Cyclosporine; Cysteine; Dithiothreitol; Intracellular Membranes; Kidney; Membrane Proteins; Mitochondria; Organotin Compounds; Permeability; Rats | 1994 |
Cystinosis and gingival hyperplasia: demonstration of cystine crystals in gingival tissue and unusual aspects of management.
Topics: Adult; Anti-Bacterial Agents; Crystallization; Cyclosporine; Cysteine; Cystinosis; Dental Care for Chronically Ill; Gingival Diseases; Gingival Hyperplasia; Humans; Kidney Transplantation; Male; Premedication | 1994 |
Drug-stimulated ATPase activity of human P-glycoprotein requires movement between transmembrane segments 6 and 12.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; ATP Binding Cassette Transporter, Subfamily B, Member 1; Colchicine; Cross-Linking Reagents; Cyclosporine; Cysteine; Humans; Membrane Glycoproteins; Movement; Protein Conformation; Protein Structure, Secondary; Recombinant Proteins; Structure-Activity Relationship; Transfection; Verapamil; Vinblastine | 1997 |
The packing of the transmembrane segments of human multidrug resistance P-glycoprotein is revealed by disulfide cross-linking analysis.
Topics: Adenosine Triphosphate; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Calcium Channel Blockers; Cell Line; Colchicine; Cross-Linking Reagents; Cyclosporine; Cysteine; Cytoplasm; Disulfides; Enzyme Inhibitors; Humans; Membrane Proteins; Mutagenesis, Site-Directed; Protein Structure, Tertiary; Temperature; Verapamil; Vinblastine | 2000 |
The immunoglobulin superantigen-binding site of HIV-1 gp120 activates human basophils.
Topics: Adult; Amino Acid Sequence; Antibodies, Anti-Idiotypic; Basophils; Binding Sites, Antibody; Cyclosporine; Cysteine; Histamine Release; HIV Envelope Protein gp120; HIV-1; HIV-2; Humans; Immunoglobulin E; Immunoglobulin M; Immunosuppressive Agents; Inflammation Mediators; Interleukin-4; Kinetics; Leukotriene C4; Leukotrienes; Molecular Sequence Data; Peptides; Receptors, IgE; Superantigens; Tacrolimus | 2000 |
Cyclophilin a binds to peroxiredoxins and activates its peroxidase activity.
Topics: Animals; Antioxidants; Ascorbic Acid; Binding Sites; Blotting, Western; Catalysis; Cyclophilin A; Cyclosporine; Cysteine; Dose-Response Relationship, Drug; Enzyme Activation; Escherichia coli; Humans; Lung; Peroxidases; Peroxiredoxin VI; Peroxiredoxins; Protein Binding; Protein Conformation; Rats; Recombinant Proteins; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Subcellular Fractions; Time Factors | 2001 |
The drug-binding pocket of the human multidrug resistance P-glycoprotein is accessible to the aqueous medium.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Biological Transport; Buffers; Cell Line; Colchicine; Cyclosporine; Cysteine; Drug Resistance, Multiple; Gene Expression Regulation; Humans; Hydrolysis; Isoleucine; Mesylates; Mutation; Rhodamines; Verapamil; Water | 2004 |
Combinatorial self-assembly of cyclophilin hCyp-18 ligands through rhenium coordination.
Topics: Aniline Compounds; Chelating Agents; Combinatorial Chemistry Techniques; Cyclophilins; Cyclosporine; Cysteine; Humans; Ligands; Molecular Structure; Oligopeptides; Proline; Protein Binding; Rhenium | 2006 |
Ca(2+) binding to c-state of adenine nucleotide translocase (ANT)-surrounding cardiolipins enhances (ANT)-Cys(56) relative mobility: a computational-based mitochondrial permeability transition study.
Topics: Adenosine Diphosphate; Animals; Calcium; Cardiolipins; Cell Membrane Permeability; Computer Simulation; Cyclosporine; Cysteine; Immunosuppressive Agents; Male; Mitochondria, Liver; Mitochondrial ADP, ATP Translocases; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Mitochondrial Swelling; Models, Chemical; Models, Molecular; Oxidative Stress; Protein Conformation; Rats; Rats, Wistar; Succinic Acid | 2009 |
S-allylcysteine attenuates renal injury by altering the expressions of iNOS and matrix metallo proteinase-2 during cyclosporine-induced nephrotoxicity in Wistar rats.
Topics: Animals; Cyclosporine; Cysteine; Immunohistochemistry; Immunosuppressive Agents; Kidney; Male; Matrix Metalloproteinase 2; Nitric Oxide Synthase Type II; Rats; Rats, Wistar | 2009 |
Mucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug delivery.
Topics: Adhesiveness; Animals; Cyclosporine; Cysteine; Lipids; Male; Mucins; Nanostructures; Ophthalmic Solutions; Particle Size; Polyethylene Glycols; Rabbits; Sulfhydryl Compounds; Swine; Tears; Viscosity | 2009 |
Going out on a LIM and cysteine-rich domains 1 limb: a new way to block calcineurin activity.
Topics: Animals; Binding Sites; Calcineurin; Cardiomegaly; Cyclosporine; Cysteine; Disease Models, Animal; DNA-Binding Proteins; Gene Expression Regulation; Homeodomain Proteins; Humans; Male; Mice | 2010 |
Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A: Improving in vivo ocular distribution.
Topics: Adhesiveness; Administration, Topical; Animals; Area Under Curve; Cross-Linking Reagents; Cyclosporine; Cysteine; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Immunosuppressive Agents; Male; Nanoparticles; Polyethylene Glycols; Rabbits; Sulfhydryl Compounds; Tissue Distribution | 2010 |
Implication of cysteine residues in the selection of oxorhenium inhibitors of cyclophilin hCyp18.
Topics: Chromatography, Liquid; Combinatorial Chemistry Techniques; Cyclophilins; Cyclosporine; Cysteine; Enzyme Inhibitors; Iodoacetamide; Kinetics; Methylation; Models, Molecular; Oxidation-Reduction; Rhenium; Spectrometry, Mass, Electrospray Ionization | 2012 |
A redox 2-Cys mechanism regulates the catalytic activity of divergent cyclophilins.
Topics: Amino Acid Sequence; Binding Sites; Catalytic Domain; Citrus sinensis; Conserved Sequence; Crystallography, X-Ray; Cyclophilins; Cyclosporine; Cysteine; Disulfides; Glutamic Acid; Models, Molecular; Molecular Sequence Data; Oxidation-Reduction; Protein Conformation; RNA Polymerase II; Thioredoxins; Zinc | 2013 |
Activating mutations in quorum-sensing regulator Rgg2 and its conformational flexibility in the absence of an intermolecular disulfide bond.
Topics: Amino Acid Substitution; Bacterial Proteins; Binding Sites; Crystallography, X-Ray; Cyclosporine; Cysteine; Dimerization; Drug Resistance, Bacterial; Kinetics; Models, Molecular; Mutagenesis, Site-Directed; Pheromones; Point Mutation; Protein Conformation; Protein Interaction Domains and Motifs; Protein Isoforms; Protein Stability; Recombinant Proteins; Static Electricity; Streptococcus pyogenes; Trans-Activators; Transcription Factors | 2017 |